Advanced search

Vol 8, No 4 (2007): Practical Diabetology
Other materials agreed with the Editors
Published online: 2007-05-17
Page views 703
Article views/downloads 0
Get Citation

Connect on Social Media

Connect on Social Media

Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes. Prevention of fluid retention

Guenther Boden, Carol Homko, Maria Mozzoli, Meijuan Zhang, Karen Kresge, Peter Cheung
Diabetologia Praktyczna 2007;8(4):135-146.

Abstract

Not available

Keywords: rosiglitazonefenofibratediabetes type 2FFA level

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Clinical Diabetology

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice